Revenue
2019
2020
2021
2022
2023
2024
2025
2026
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.00B | $1.90B | $1.79B | $1.90B | $1.78B | $1.37B | $1.28B | $1.19B | $1.53B | $1.54B | $1.17B | $916.6M | $714.3M | $809.8M | $426.8M | $369.6M | $221.0M |
| Gross profit | $1.05B | $996.0M | $916.1M | $957.0M | $923.6M | $707.3M | $674.2M | $597.5M | $760.7M | $757.8M | $554.8M | $425.7M | $356.2M | $395.2M | $230.4M | $202.0M | $118.7M |
| Research & development | $434.0M | $434.7M | $426.5M | $458.4M | $406.3M | $342.8M | $347.6M | $375.1M | $366.4M | $303.7M | $269.2M | $197.9M | $126.2M | $114.1M | $85.7M | $63.9M | $51.4M |
| Operating expenses | $593.8M | $585.7M | $572.6M | $707.9M | $557.3M | $470.1M | $500.7M | $496.7M | $498.3M | $440.8M | $374.6M | $317.0M | $201.1M | $194.4M | $150.9M | $118.7M | $93.3M |
| Operating income | $460.4M | $410.4M | $343.5M | $249.0M | $366.3M | $237.2M | $173.5M | $100.8M | $262.5M | $317.1M | $180.2M | $108.8M | $155.0M | $200.8M | $79.5M | $83.3M | $25.4M |
| EBITDAderived | $512.7M | $461.3M | $391.8M | $320.2M | $428.4M | $284.3M | $241.7M | $180.6M | $343.9M | $380.5M | $238.3M | $143.6M | $169.9M | $214.4M | $89.5M | $91.5M | $33.3M |
| Net income | $414.4M | $331.5M | $274.6M | $176.7M | $326.4M | $217.3M | $159.5M | $90.0M | $162.0M | $261.2M | $123.6M | $55.2M | $108.1M | $136.6M | $88.0M | $203.5M | $38.4M |
| Basic EPSper diluted share | $8.10 | $6.24 | $5.06 | $3.18 | $5.70 | $3.74 | $2.74 | $1.50 | $2.55 | $4.12 | $1.96 | $0.88 | $1.72 | $2.12 | $1.35 | $3.00 | $0.59 |
| Diluted EPSper diluted share | $7.85 | $6.00 | $4.90 | $3.09 | $5.52 | $3.62 | $2.64 | $1.46 | $2.46 | $3.92 | $1.87 | $0.85 | $1.65 | $2.00 | $1.29 | $2.82 | $0.59 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 29, 2026Form 4 · 10b5-1 | Brannan AndrewEVP, Worldwide Sales | SellCommon Stock | 6.5K | $144.71 | $935.4K | 7.2K |
| Jun 22, 2026Form 4 · 10b5-1 | Baumgartner Jeffrey WEVP, R&D | SellCommon Stock | 1.2K | $168.23 | $196.8K | 16.4K |
| Jun 3, 2026Form 4 · 10b5-1 | THOMAS SCOTTEVP, General Counsel | SellCommon Stock | 1.3K | $180.04 | $234.1K | 31.0K |
| Jun 2, 2026Form 4 · 10b5-1 | Baumgartner Jeffrey WEVP, R&D | SellCommon Stock | 3.9K | $168.54 | $658.5K | 17.6K |
| May 29, 2026Form 4 · 10b5-1 | Baumgartner Jeffrey WEVP, R&D | SellCommon Stock | 11.2K | $171.65 | $1.92M | 17.6K |